Puberty blockers trial paused after MHRA raises safety concerns


“Since potentially significant and, as yet, unquantified risk of long-term biological harms is present to participants and biological safety has not been definitively demonstrated in this proposed cohort, at the very least, there should be a graded/stepwise approach starting with those aged 14 as the lower limit of eligibility,” it reads.



Source link


Discover more from News Link360

Subscribe to get the latest posts sent to your email.

Leave a Reply

Discover more from News Link360

Subscribe now to keep reading and get access to the full archive.

Continue reading